Publish date: 14 March 2022
A clinical research unit in Swindon has recruited the first UK patient to take part in a worldwide study to examine whether a diabetes drug can be used in the treatment for early Alzheimer's disease.
The Kingshill Research Centre, which is run by Avon and Wiltshire Mental Health Partnership (AWP) NHS Trust and is located at the Victoria Centre on the Great Western Hospital site in Swindon, is recruiting patients with vascular dementia, as well as Alzheimer's for the trial.
Helen Cartwright, Senior Research Nurse at the Kingshill Research Centre, said: "This is great news for the team looking into potential treatments for people with Alzheimer's and dementia. This study is looking to recruit around 1,800 people in approximately 40 countries around the world, so to have recruited the first UK participant is really exciting. If the trial shows positive results it could revolutionise treatments for many people living with dementia."
Kingshill Research Centre has an international reputation for its work with Alzheimer's studies, and is excited to continue to help more patients access the trial.
Helen continued: "We're looking for men and women, aged between 55 and 85 to take part. They must have a diagnosis of Mild Cognitive Impairment (MCI) or mild dementia of the Alzheimer's type and be willing to visit the centre approximately 17 times and receive one phone call during a three year period."
For more details about the trial click here
If you would like more information about the studies the Kingshill Research Centre is currently recruiting patients for, please contact the team on 01793 327 954 or by email - awp
